Pangraf 5MG Capsule (10’s) is a prescription medication that contains Tacrolimus as its active ingredient, with each capsule delivering a dosage of 5mg. This drug is primarily used as an immunosuppressant, playing a crucial role in preventing organ rejection in patients who have undergone transplants, such as kidney, liver, or heart transplants. By inhibiting the activity of T-lymphocytes, which are a type of white blood cell involved in the immune response, Pangraf helps to reduce the body’s natural defense mechanisms against the transplanted organ, thereby enhancing the chances of successful transplantation. In addition to its use in transplant patients, Tacrolimus is also indicated for certain autoimmune conditions, making it a versatile medication in the field of immunology. The formulation of Pangraf is designed for oral administration, providing a convenient option for patients who require long-term treatment. As with any medication, it is essential to follow the prescribed dosage and consult healthcare professionals for any concerns regarding its use.

Pangraf 2MG Capsule is a medication that contains Tacrolimus as its active ingredient, specifically formulated to aid in the prevention of organ rejection in patients who have undergone transplants, such as kidney, liver, or heart transplants. This immunosuppressant works by inhibiting the activation of T-lymphocytes, which are crucial components of the immune system that can attack transplanted organs. Each capsule contains 2mg of Tacrolimus, and the medication is typically packaged in a blister pack of 10 capsules. Pangraf is essential for patients who require long-term immunosuppression to maintain the viability of their transplanted organs, thereby improving their quality of life and overall health outcomes. The drug is often prescribed alongside other immunosuppressive agents to enhance its effectiveness and minimize the risk of rejection.

Pangraf 1MG Capsule is a medication that contains Tacrolimus as its active ingredient, specifically formulated to aid in the prevention of organ rejection in patients who have undergone organ transplants, such as kidney, liver, or heart transplants. This immunosuppressant works by inhibiting the immune system’s response, thereby reducing the likelihood of the body rejecting the transplanted organ. Each capsule contains 1mg of Tacrolimus, which is a potent agent that helps maintain the balance of immune function necessary for transplant success. Pangraf is typically prescribed as part of a comprehensive post-transplant care regimen, often in conjunction with other immunosuppressive medications to enhance efficacy and minimize the risk of rejection. The drug is available in a pack of 10 capsules, making it convenient for patients to manage their medication schedule effectively.

Pangraf 0.25MG Capsule is a medication that contains Tacrolimus as its active ingredient, specifically formulated to aid in the prevention of organ rejection in patients who have undergone organ transplants, such as kidney, liver, or heart transplants. This immunosuppressant works by inhibiting the activation of T-lymphocytes, which are crucial components of the immune system that can attack transplanted organs. Each capsule contains 0.25mg of Tacrolimus, and it is typically prescribed as part of a comprehensive immunosuppressive regimen that may include other medications to enhance its effectiveness. Pangraf is essential for patients who require long-term immunosuppression to maintain the viability of their transplanted organs, thereby improving their quality of life and overall health outcomes.